The CLSA upgrade from Underperform to Hold, while modest, represents a meaningful shift in sentiment from a previously bearish firm, but the downgrade in EPS estimates and insider selling temper the bullish signal. The elevated short interest at 60.1% could fuel a squeeze if positive catalysts emerge, but the lack of earnings date proximity reduces urgency.
Price Chart
Executive Summary
On October 22, 2026, CLSA upgraded Tesla (TSLA) from Underperform to Hold, raising its price target to $400 from $310, a 29% increase. BNP Paribas also upgraded TSLA from Underperform to Neutral with a $420 target, creating a cluster of positive revisions from previously bearish firms. CLSA has a 53% accuracy rate on 17 scored calls with an average return of 17.2%, placing it below the top-tier firms covering TSLA. The consensus on TSLA is mixed: 27 of 54 analysts rate it Buy (50%), 22 rate it Hold (41%), and 5 rate it Sell (9%). The mean price target is $397.83, median $412.50, high $600, low $128.11, with the current price at $386.47 implying a 2.9% upside to the mean. CLSA's new $400 target is slightly above the mean but below the median, aligning with the consensus range. Analyst momentum is positive with 2 upgrades and 0 downgrades in the last 30 days, though EPS revisions are trending lower: the current fiscal year estimate fell from $1.78 to $1.41 over 30 days, and the next fiscal year estimate dropped from $2.20 to $2.17. Insider selling was recorded on September 8, 2026, with Vaibhav Taneja selling approximately $938,419 worth of shares, a modest amount. Institutional activity shows mixed signals: Congress Asset Management doubled its position (13,083% increase), while FJARDE AP-FONDEN trimmed by 40.2%. Short interest stands at 60.1% of TRF volume, indicating elevated bearish positioning. The bottom line: CLSA's upgrade from Underperform to Hold, while modest, represents a meaningful shift in sentiment from a previously bearish firm, but the downgrade in EPS estimates and insider selling temper the bullish signal.
Impact Score
Consensus & Targets
The consensus on TSLA is mixed: 10 Strong Buy, 17 Buy, 22 Hold, 5 Sell, 0 Strong Sell, totaling 54 analysts. 50% rate it Buy (27 analysts), 41% Hold (22 analysts), and 9% Sell (5 analysts). The consensus is leaning bullish but with significant hold sentiment.
The mean price target is $397.83, median $412.50, high $600, low $128.11. The current price is $386.47, implying a 2.9% upside to the mean and a 6.7% upside to the median. CLSA's $400 target is slightly above the mean but below the median, placing it in the middle of the consensus range.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-22 | CLSA | upgrade | Hold | $400.00 |
| 2026-10-22 | Canaccord Genuity | maintain | Buy | $442.00 |
| 2026-10-22 | Morgan Stanley | maintain | Equal-Weight | $410.00 |
| 2026-10-22 | BNP Paribas | upgrade | Neutral | $420.00 |
| 2026-10-22 | RBC Capital | reiterate | Outperform | $480.00 |
| 2026-10-22 | JP Morgan | maintain | Neutral | $430.00 |
| 2026-10-22 | TD Cowen | reiterate | Buy | $460.00 |
| 2026-10-22 | Piper Sandler | maintain | Overweight | $475.00 |
| 2026-10-22 | StoneX | reiterate | Buy | $475.00 |
| 2026-10-22 | GLJ Research | reiterate | Sell | $24.86 |
In the last 30 days, there have been 2 upgrades and 0 downgrades on TSLA. EPS revisions are trending lower: the current fiscal year estimate fell from $1.78 to $1.41 over 30 days (9 downgrades vs 4 upgrades), and the next fiscal year estimate dropped from $2.20 to $2.17 (10 downgrades vs 1 upgrade). The current quarter estimate saw 7 downgrades vs 4 upgrades. Overall, estimates are being revised lower.
Firm Track Record — CLSA
CLSA accuracy: 53% on 17 calls | avg return: 17.2%
Industry benchmark: mean 51% ± 10%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Jefferies | 100% | 3/3 | 53.8% | top tier |
| RBC Capital | 93% | 13/14 | 33.7% | top tier |
| Piper Sandler | 85% | 11/13 | 32.7% | top tier |
| Canaccord Genuity | 80% | 12/15 | 28.5% | top tier |
| Roth MKM | 80% | 4/5 | 29.9% | top tier |
| Oppenheimer | 80% | 4/5 | 26.6% | top tier |
| Citigroup | 80% | 4/5 | 19.3% | top tier |
| Cantor Fitzgerald | 79% | 27/34 | 31.7% | top tier |
| Goldman Sachs | 79% | 11/14 | 22.5% | top tier |
| Needham | 78% | 7/9 | 24.6% | top tier |
CLSA has a 53% accuracy rate on 17 scored calls with an average return of 17.2%, placing it below the top-tier firms covering TSLA. Top-tier firms include Jefferies (100% on 3 calls, avg return 53.8%), RBC Capital (93% on 14 calls, avg return 33.7%), and Piper Sandler (85% on 13 calls, avg return 32.7%). The worst-performing firm in the dataset is GLJ Research, which reiterates a Sell rating with a $24.86 target, though its accuracy is not listed.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $2.17 | $1.40 — $3.67 | $121.7B | ↑1 ↓0 |
| 0y | $1.41 | $1.41 — $1.41 | $107.3B | ↑2 ↓0 |
| 0q | $0.49 | $0.33 — $0.83 | $28.8B | ↑5 ↓0 |
| +1q | $0.47 | $0.24 — $0.90 | $26.2B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades show a single sell on September 8, 2026, by Vaibhav Taneja for approximately $938,419, a modest amount that may be liquidity-driven. Congressional trades show two small sells by Democrats Gilbert Cisneros and Ro Khanna in August 2026, each in the $1,001-$15,000 range. Institutional activity is mixed: Congress Asset Management doubled its position (13,083% increase), Assenagon Asset Management added 26.5%, while FJARDE AP-FONDEN trimmed by 40.2%. Short interest is elevated at 60.1% of TRF volume, indicating significant bearish positioning. The insider sell and high short interest diverge from the positive analyst upgrades, creating a mixed signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | ANALYST-UPGRADE | $381.56 | awaiting T+5 | — | $372.22 (−2.45%) |
Oct 22, 2026 4d ago | ANALYST-UPGRADE | $374.58 | awaiting T+5 | — | $372.22 (−0.63%) |
Oct 22, 2026 5d ago | Court Ruling | $372.22 | awaiting T+5 | — | $372.22 (+0.00%) |
Oct 21, 2026 5d ago | 8-K | $374.58 | awaiting T+5 | — | $372.22 (+0.63%) |
Oct 19, 2026 7d ago | DEFA14A | $373.71 | awaiting T+5 | — | $372.22 (−0.40%) |
Oct 19, 2026 7d ago | DEFA14A | $368.06 $391.62 | ▲ +6.40% | ▲ +6.55% | $372.22 (+1.13%) |
Oct 19, 2026 7d ago | DEFA14A | $368.06 $391.62 | ▲ +6.40% | ▲ +6.55% | $372.22 (+1.13%) |
Oct 19, 2026 7d ago | DEFA14A | $368.06 $391.62 | ▲ +6.40% | ▲ +6.55% | $372.22 (+1.13%) |
Oct 19, 2026 7d ago | DEF 14A | $368.06 $391.62 | ▲ +6.40% | ▲ +6.55% | $372.22 (+1.13%) |
Oct 15, 2026 11d ago | Institutional Cluster | $362.44 $374.58 | ▲ +3.35% | ▲ +4.36% | $372.22 (+2.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers